VolitionRx
VolitionRx Prices $2.3M Registered Direct Offering
Proceeds from the offering will be used for research and continued product development, clinical studies, and product commercialization.
In Brief This Week: Count Me In, VolitionRx, CareDx, Centogene, Golden Helix, TeleRare Health, More
News items for the week of March 10, 2025
In Brief This Week: Nautilus Biotechnology, Guardant Health, VolitionRx, BioTechne, More
News items for the week of March 3, 2025
Volition Eyes East Asia Expansion With Nucleosome-Based Blood Test for Lung Cancer Screening
Premium
The firm hopes to include its lung cancer assay in Taiwan's national cancer screening program while developing sepsis and ovarian cancer assays.
People in the News at Sophia Genetics, Standard BioTools, VolitionRx, Biocartis, Ribbon Bio, More
Recently posted executive and academic appointments, promotions, and departures in omics and molecular diagnostics.
Jun 1, 2023
VolitionRx Prices $16.5M Public Offering
Feb 17, 2023
VolitionRx Prices $7.5M Public Offering
Jul 29, 2022